is glp 1 patented Medicines Patent Pool Executive Director Charles Gore tells Devex that one of his priorities in his last year on the job to get a license for GLP-1 therapies. But he admits Patent and Innovation Trends in

Understanding the pros and cons of each can help you make an informed choice that best fits your needs

It is a key component of sleep health and varies significantly by age, lifestyle, and individual needs

Quotes from industry leaders like Neeraj Sharma (One-Source Specialty Pharma) and others underline that regulatory infrastructure and specialised capabilities remain the biggest challenges, even where basic capacity exists

Clinical trials supporting semaglutide's weight loss efficacy did not show significant differences in outcomes based on time of day, suggesting that consistency matters far more than clock precision

The imbalance of gut microbiota will reduce the production of SCFAs, weaken the ability to activate SCFAs receptors, and affect GLP-1 secretion, resulting in abnormal glucose metabolism and lipid metabolism (Ma et al., 2019)